Publication: Evaluation of the effect of short-term treatment with the integrase inhibitor raltegravir (Isentress TM) on the course of progressive feline leukemia virus infection
Evaluation of the effect of short-term treatment with the integrase inhibitor raltegravir (Isentress TM) on the course of progressive feline leukemia virus infection
Date
Date
Date
Citations
Bösch, A. C. (2012). Evaluation of the effect of short-term treatment with the integrase inhibitor raltegravir (Isentress TM) on the course of progressive feline leukemia virus infection. (Dissertation, University of Zurich) https://doi.org/10.5167/uzh-74265
Abstract
Abstract
Abstract
Cats progressively infected with the gammaretrovirus feline leukemia virus (FeLV) are at high risk to die within a few months to years due to several disease symptoms that range from immune suppression, to anemia and lymphoma/ leukemia. Up to now, there is no specific drug available to treat FeLV infection. In the present study an in vivo experiment was performed to investigate if a short- term treatment with the integrase inhibitor raltegravir can effectively suppress FeLV replication, allowing the immune system to overcome the infec
Additional indexing
Creators (Authors)
Faculty
Faculty
Faculty
Item Type
Item Type
Item Type
Referees
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Place of Publication
Place of Publication
Place of Publication
Publication date
Publication date
Publication date
Date available
Date available
Date available
Number of pages
Number of pages
Number of pages
OA Status
OA Status
OA Status
Citations
Bösch, A. C. (2012). Evaluation of the effect of short-term treatment with the integrase inhibitor raltegravir (Isentress TM) on the course of progressive feline leukemia virus infection. (Dissertation, University of Zurich) https://doi.org/10.5167/uzh-74265